Sally is Founder and CEO of Curley Global IR (CGIR), LLC, an Investor Relations (IR), Environmental-Social-Governance (ESG) and Corporate Governance strategic advisory firm. With more than 30 years of business experience, Sally has worked for and represented companies in the healthcare, high tech, software and retail industries. Her expertise includes: building and leading IR, ESG, corporate governance outreach programs; strategic consulting and planning; advisor to public, private and non-profit Boards; IPOs (traditional and tracking stocks). From 2010 to 2017, she was named a top IR Officer in her industry by Institutional Investor Magazine and in 2012 was named one of Treasury and Risk Magazine’s “30 Outstanding Women in Finance.” In 2019 she received the prestigious IR Magazine Lifetime Achievement award, an honor awarded by her peers.
For nearly a decade, Sally served as Senior Vice President, Investor Relations for Cardinal Health, a Fortune 50 global healthcare services company, where she oversaw worldwide IR and corporate governance outreach efforts. She was a member of the company’s Global Leadership Team as well as its Disclosure Committee. While there, Sally co-founded and co-chaired the company’s first cross-functional committee responsible for assessing and advancing ESG (environmental, social and governance) initiatives. Prior to Cardinal Health, Sally was Vice President, Investor Relations for Genzyme Corporation (now Sanofi), where she led global IR and helped to advise the Nominating and Governance Board Committee on governance issues. In both organizations, she grew the domestic and international shareholder base substantially.
Sally has presented numerous times to the U.S. Securities and Exchange Commission Corporate Finance Division on topics related to IR, disclosure, ESG and proxy process reform. She also has authored Comment Letters to the SEC on behalf of the organizations with whom she worked.
Sally served on the National Investor Relations Institute’s (NIRI’s) Board of Directors, its Senior Roundtable Steering Committee and as a past President of the Boston Chapter. She currently sits on NIRI’s Ethics Committee. In 2013 Sally was inducted into NIRI’s inaugural Class of Fellows, “recognized leaders who represent the ideals of the investor relations profession.” She chaired the committee responsible for creating the NIRI Body of Knowledge, used as the basis for a new IR Certification (IRC). A member of the Society for Corporate Governance, Sally serves on its Sustainability Committee.
Sally currently sits on the Advisory Board for MOBILion Systems, Inc., a private company enabling advancements in disease diagnosis and treatment through its proprietary analytical instrumentation. In addition, she has served as member of the Board of Directors for several non-profit organizations, including the Columbus Zoo and Aquarium (one of the nation’s largest) where she chaired the Board’s Sustainability Committee and was a member of its Nominating and Governance Committee.
Sally is an Adjunct Faculty member at Georgetown University for its Executive Master’s in Global Communications program. She has guest-lectured / taught at The Ohio State University, Boston University, Emerson College Graduate School of Communications and Harvard University on IR, ESG, corporate governance, disclosure issues and crisis communications, including creating coursework related to the healthcare industry. She holds a B.A. from Colby College in Waterville, ME, an M.B.A. from Northeastern University in Boston, MA, and a Certificate of Biotechnical Education from Boston University Medical School.
The IR Magazine Awards – US 2024 will take place on Wednesday, March 27 in New York. This very special event honors excellence in the investor relations profession across the US.
IR Magazine are long-term supporters of the 
